GAITHERSBURG, Md.--(BUSINESS WIRE)--BGI, the largest genomics organization in the world, and OpGen, Inc., a commercial phase genomics company and exclusive provider of Optical Mapping Technology, announced their joint effort to expand the use of Optical Mapping for de novo sequence finishing in human, plant and animal genomes.
